Another top neurosurgeon has endorsed TissuePatchDural following our recent coverage of a burst pressure study from Japan. Published in the journal Spine, the Japanese paper suggested that use of a polylactide sheet, glued in place using a cocktail of fibrin/thrombin adhesive solutions, could achieve satisfactory closure of dural defects up to 5mm in an ex-vivo setting. Tissuemed’s observation was that such a complex hybrid approach using an array of materials could be avoided with the use of a single product – TissuePatchDural – our own self-adhesive film is applied in 30 seconds and delivers burst pressure resistance at the top of the range quoted in the Japanese paper, of around 150mmHg.
Consultant Neurosurgeon Scott Rutherford, from Salford Royal NHS Foundation Trust made the following comments about the Japanese study results:
“These results highlight the limitations of fibrin spray used in isolation or with other repair materials. In contrast, my clinical experience of TissuePatchDural is that it seals in a far more reliable way both for tiny holes in a dural suture line as well as larger dural defects up to 5mm. The in vitro burst pressure figures are confirmation of just how well TPD compares.”
It’s always incredibly rewarding to receive positive feedback from our supportive surgical community, especially when it endorses our own work.
Tissuemed’s dedicated neurosurgical sealant product, TissuePatchDural is supported by a body of clinical evidence that bears out our extensive benchtop work.